Addressing noncommunicable diseases
Psoriasis and its comorbidities
4 September 2017
By IFPA
Psoriatic disease is characterized by increased risk of developing related noncommunicable diseases. The most common comorbidities are obesity, hypertension, dyslipidemia, diabetes (collectively referred to as metabolic syndrome), cardiovascular disease, and inflammatory bowel disease. Due to the risk of developing these diseases, psoriatic disease must be addressed early, holistically and efficiently.
Related content
tool Advocacy, Toolkits
Design it right: A checklist for diverse, equitable, patient-first trials
tool Advocacy, Toolkits
Glossary: Common terms in clinical research
tool Advocacy, Toolkits
Before you join a study: A practical guide for participation in clinical trials
tool Advocacy, Toolkits
Breaking The Myths: Clinical trials and psoriatic disease
Article Advocacy, News
“Health right is a human right”
Article Advocacy, News
“We want to raise awareness and break stigma around psoriasis in Paraguay”
Article Advocacy, News
Patient organizations are crucial to achieving equitable healthcare globally